This study is aimed at expressing HIV-1 Pol and Gag genes in the monitoring of HIV-1 patients on HAART in Federal Medical Centre, Lokoja, Kogi State, Nigeria, that randomly recruited 75 participants within the age range of 18 and 65 years with a population- based sample of males and females divided into three groups designated A to C; comprising of 25 HIV-1 seropositive individuals on HAART (TDF + 3TC + EFV) designated as group A, 25 HIV-1 seropositive individuals on HAART (AZT + 3TC +NVP) designated as group B, and 25 HAART naïve HIV-1 seropositive individuals designated as control group C. Blood samples were taken and analyzed using ELISA for p24 antigen, HIV-1 protease and reverse transcription-polymerase chain reaction for HIV-1 Gag-Pol genes. The PCR products were analyzed on 1% agarose gel electrophoresis. Data were analyzed using SPSS software application (version 25.0) and expressed as mean ± standard error of mean. The results showed a significant difference in p24 antigen and HIV-1 protease in group A (9.64 ± 5.34 and 5.48 ± 6.62) when compared to control (16.3 ± 3.68 and 26.68 ± 11.71) (p<0.05). There was also a significant difference in p24 antigen and HIV-1 protease in group B (13.01 ± 5.19 and 20.47 ±7.53) when compared to control (16.3 ± 3.68 and 26.68 ± 11.71) (p<0.05). The gene expression of HIV-1 Pol is broadly expressed compared to the HIV-1 Gag gene expression. The negative Gag expression could be due to decrease in p24 antigen as the antibody increases.
No takes yet. Share an insight, caveat, or question.
Isaac et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: